# OnCo record pcr (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/pcr/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "pcr" ;
  schema:name "Pathologic complete response (pCR)"@en ;
  schema:alternateName "pathological complete response"@en, "ypT0"@en, "ypN0"@en, "non-pCR"@en, "residual invasive disease"@en, "residual disease after neoadjuvant"@en ;
  schema:description "No invasive cancer left in the breast and lymph nodes when the surgeon removes the tissue after pre-surgery treatment."@en ;
  schema:url <https://onco.cc/terms/pcr/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03036488>, <https://clinicaltrials.gov/study/NCT05812807>, <https://doi.org/10.1016/s0140-6736(13)62422-8>, <https://doi.org/10.1200/jco.2007.14.4147>, <https://doi.org/10.1056/nejmoa1910549> ;
  onco:related <https://onco.cc/terms/surrogate-validation/>, <https://onco.cc/terms/surrogate-endpoint/>, <https://onco.cc/terms/efs/>, <https://onco.cc/terms/window-of-opportunity-trial/>, <https://onco.cc/terms/neoadjuvant-adjuvant/>, <https://onco.cc/terms/response-adaptive-randomisation/> ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/breast-her2-positive/>, <https://onco.cc/cancers/tnbc-early/> ;
  onco:trials <https://onco.cc/trials/keynote-522/>, <https://onco.cc/trials/optimice-pcr/> .